Terms of Service
These Terms of Service (“Terms”) are a binding agreement between you and PixelPort LLC(“Myo,” “we,” “us,” or “our”) governing your use of the Myo mobile application and related services (the “App”).
BY DOWNLOADING, ACCESSING, OR USING THE APP, YOU AGREE TO THESE TERMS. IF YOU DO NOT AGREE, DO NOT USE THE APP.
Please read Sections 1 to 4 (medical disclaimers), Section 12 (limitation of liability), and Section 14 (arbitration and class-action waiver) carefully. They affect your legal rights.
1. Medical Disclaimer, Tracking and Education Only
1.1 Myo is a tracking and educational tool only. It does not provide medical advice, does not diagnose conditions, does not treat side effects, does not recommend or determine dose changes, and does not replace your healthcare provider.
1.2 Myo is not a medical device. It does not diagnose, treat, cure, mitigate, or prevent any disease or medical condition.
1.3 Nothing in the App, including dose information, medication-level estimates, body-composition values, insights, notifications, or nutrition estimates, is medical advice or a substitute for professional medical care. Always consult your prescriber or a qualified healthcare provider about medication decisions, dosing, side effects, or any health concern. Never disregard professional medical advice or delay seeking it because of something in the App.
1.4 Information about medications shown in the App (including brand names and label strengths) is provided for logging and reference convenience only and reflects information published by manufacturers. It is not a representation that any medication is appropriate for you.
2. No Doctor to Patient Relationship
Your use of the App does not create a doctor to patient, provider to patient, or any other healthcare relationship between you and Myo, PixelPort LLC, or anyone associated with the App. Myo does not practice medicine and provides no clinical services.
3. Dosing Disclaimer
3.1 Dose and medication information shown in the App reflects label strengths published by manufacturers and values you enter, for logging convenience only.
3.2 The App’s dose-logging helpers and reconstitution references perform arithmetic on values you provide; they do not recommend, prescribe, or validate any dose. Do not change your dose, timing, frequency, or medication based on anything shown in the App.
3.3 All dosing decisions must be made by your licensed prescriber.Any “plan,” “next step,” titration schedule, or taper schedule shown in the App reflects information you entered and is not a recommendation that you take any particular dose. Confirm everything with your prescriber.
4. Medication-Level (PK) and Body-Composition Estimates
4.1 The medication-level curve is a population-average estimate generated from a pharmacokinetic model based on published clinical data. It is not a measurement of your actual drug levels. Individual metabolism varies substantially (roughly 2 to 3 times from the average). Do not use this estimate to make dosing or health decisions.
4.2 Body-composition and nutrition values you enter or import (from smart scales, DEXA/InBody scans, Apple Health, or the Smart Photo estimate) are provided for informational and trend-tracking purposes only. They are not a clinical diagnostic measurement and do not constitute a medical assessment. Consult your healthcare provider for clinical interpretation.
5. Emergencies
If you are experiencing a medical emergency, call 911 (or your local emergency number) immediately. The App cannot and will not contact emergency services, monitor your health in real time, or respond to a medical crisis. Do not rely on the App in any urgent or emergency situation.
6. No Guarantee of Results
Results vary by individual. The App tracks your data, it does not guarantee any health outcome, weight-loss result, body-composition change, or medication effectiveness. Any statistics or general information presented are educational and may not reflect your individual results.
7. Trademarks and No Affiliation
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. All other product and brand names are the property of their respective owners. Myo is not affiliated with, endorsed by, or sponsored by Novo Nordisk A/S, Eli Lilly and Company, or any other pharmaceutical manufacturer. Brand names are referenced solely to help you log your prescribed medication.
8. HIPAA Clarification
Myo is not a HIPAA-covered entity and is not a business associate of one. Your data is protected under our Privacy Policyand applicable state and consumer privacy laws, not HIPAA. We do not claim to be “HIPAA compliant,” and we do not sell your health data.
9. Assumption of Risk
You acknowledge and agree that you use the App at your own risk. You are solely responsible for your medical decisions and for verifying any information with your prescriber or healthcare provider. To the maximum extent permitted by law, you assume all risk arising from your use of the App, including reliance on any logged data, estimate, insight, or automated nutrition estimate.
10. Smart Photo and Automated Estimates
10.1 Smart Photo and the App’s other automated estimates (such as on-device or cloud nutrition estimation) are convenience tools. They are not a human, not a healthcare provider or dietitian, and do not give medical, dietary, or dosing advice. They provide rough informational estimates only.
10.2 Automated estimates can be inaccurate, incomplete, or out of date. Do not rely on them for medical or nutrition decisions. The cloud Smart Photo feature is optional and off by default; you control it in Settings, as described in our Privacy Policy. Use of these features is subject to Sections 1 to 9 and the rest of these Terms.
11. License, Intellectual Property, and User Content
11.1 Our IP.The App and all of its content, software, design, text, graphics, and trademarks (excluding third-party trademarks referenced under Section 7) are owned by PixelPort LLC or its licensors and are protected by intellectual-property laws. We grant you a limited, personal, non-exclusive, non-transferable, revocable license to use the App for your personal, non-commercial use, subject to these Terms and Apple’s Licensed Application End User License Agreement.
11.2 Restrictions. You may not copy, modify, reverse-engineer, decompile, resell, or create derivative works from the App except as permitted by law.
11.3 Your content.You retain ownership of the data and content you submit (“User Content”). You grant us a limited, worldwide, royalty-free license to host, store, process, and display your User Content solely to operate and provide the App to you and as described in our Privacy Policy. We do not claim ownership of your User Content and do not use your health data for advertising.
11.4 Feedback. If you send us suggestions or feedback, you grant us a perpetual, royalty-free license to use it without obligation to you.
12. Limitation of Liability
12.1 TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE APP IS PROVIDED “AS IS” AND “AS AVAILABLE,” WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT.
12.2 TO THE MAXIMUM EXTENT PERMITTED BY LAW, MYO AND PIXELPORT LLC, AND THEIR OFFICERS, EMPLOYEES, AND AGENTS, SHALL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES, OR FOR ANY LOSS OF PROFITS, DATA, GOODWILL, OR HEALTH OUTCOMES, ARISING FROM OR RELATED TO YOUR USE OF (OR INABILITY TO USE) THE APP, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
12.3 TO THE MAXIMUM EXTENT PERMITTED BY LAW, OUR TOTAL AGGREGATE LIABILITY FOR ALL CLAIMS ARISING FROM OR RELATED TO THE APP OR THESE TERMS SHALL NOT EXCEED THE GREATER OF (A) THE AMOUNT YOU PAID US FOR THE APP IN THE TWELVE (12) MONTHS BEFORE THE EVENT GIVING RISE TO THE CLAIM, OR (B) US $50.00.
12.4 Some jurisdictions do not allow certain limitations; in those jurisdictions our liability is limited to the maximum extent permitted by law. Nothing in these Terms limits liability that cannot be limited by law (such as for fraud or, where applicable, death or personal injury caused by negligence).
13. Indemnification
You agree to indemnify, defend, and hold harmless Myo, PixelPort LLC, and their officers, employees, and agents from and against any claims, damages, losses, liabilities, and expenses (including reasonable attorneys’ fees) arising from or related to: (a) your use or misuse of the App; (b) your violation of these Terms or any law; (c) your medical or dosing decisions; or (d) your violation of any third-party right. This obligation survives termination of these Terms.
14. Dispute Resolution, Arbitration and Class-Action Waiver
PLEASE READ THIS SECTION CAREFULLY. IT REQUIRES DISPUTES TO BE RESOLVED BY BINDING ARBITRATION AND WAIVES YOUR RIGHT TO A JURY TRIAL AND TO PARTICIPATE IN A CLASS ACTION.
14.1 Binding arbitration. Except as provided below, any dispute, claim, or controversy arising out of or relating to the App or these Terms shall be resolved by final and binding arbitration administered by the American Arbitration Association (AAA) under its then-current applicable rules. The arbitration shall be held in Pinellas County, Florida or conducted by videoconference, and judgment on the award may be entered in any court of competent jurisdiction. The Federal Arbitration Act governs the interpretation and enforcement of this Section.
14.2 Class-action waiver. You and Myo agree that each may bring claims against the other only in an individual capacity, and not as a plaintiff or class member in any purported class, collective, consolidated, or representative proceeding. The arbitrator may not consolidate more than one person’s claims and may not preside over any form of class proceeding.
14.3 Exceptions. Either party may (a) bring an individual claim in small-claims court, and (b) seek injunctive or equitable relief in court for intellectual-property infringement or unauthorized access.
14.4 Opt-out. You may opt out of this arbitration agreement by sending written notice to [email protected] within 30 days of first accepting these Terms.
14.5 Severability. If the class-action waiver in 14.2 is found unenforceable as to a particular claim, that claim shall proceed in court; the rest of this Section survives.
15. Governing Law
These Terms are governed by the laws of the State of Florida, United States of America, without regard to its conflict-of-laws rules, except that the Federal Arbitration Act governs Section 14. Subject to Section 14, the state and federal courts located in Pinellas County, Florida have exclusive jurisdiction over any matter not subject to arbitration.
16. Subscriptions and Auto-Renewal
16.1 Some features require a paid, auto-renewing subscription(“Myo Premium”), sold through the Apple App Store and managed via RevenueCat.
16.2 The price (currently US $39.99 per year for the annual plan, or US $8.99 per month for the monthly plan, where an introductory free trial may apply) is charged to your Apple ID account at confirmation of purchase. Your subscription automatically renews at the then-current price unless you turn off auto-renew at least 24 hours before the end of the current period. Your account is charged for renewal within 24 hours before the end of the current period. Prices may vary by region and over time, and the price shown at the point of purchase controls.
16.3 If a free trial is offered, any unused portion of the free trial is forfeited when you purchase a subscription.
16.4 You can manage or cancel your subscription in your Apple ID Account Settingsafter purchase. Purchases and refunds are handled by Apple under Apple’s terms; we generally do not control Apple’s refund decisions.
16.5 Subscriptions are also subject to Apple’s Licensed Application End User License Agreement and the auto-renew disclosures shown at the point of purchase.
17. Age Requirement
The App is intended for users aged 18 and older. By using the App, you represent and warrant that you are at least 18 years of age and have the legal capacity to enter into these Terms. We do not knowingly permit anyone under 18 to use the App.
18. Modifications to the App and These Terms
We may modify, suspend, or discontinue any part of the App at any time. We may update these Terms; if we make material changes, we will update the effective date and, where required, provide notice. Your continued use of the App after changes take effect constitutes acceptance of the revised Terms.
19. Termination
We may suspend or terminate your access to the App at any time for any violation of these Terms or for any lawful reason. You may stop using the App at any time. Sections that by their nature should survive (including Sections 1 to 14, 18, and 20 to 22) survive termination.
20. Account Deletion
You may delete your account and associated data directly within the App (Settings, then Account, then Delete account) or by contacting us at [email protected]. Deletion is handled as described in our Privacy Policy.
21. Severability and Entire Agreement
If any provision of these Terms is held unenforceable, that provision will be limited or severed to the minimum extent necessary, and the remaining provisions remain in full force. These Terms, together with the Privacy Policy and Apple’s applicable terms, constitute the entire agreement between you and Myo regarding the App and supersede any prior agreements. Our failure to enforce any provision is not a waiver.
22. Apple-Specific Terms
You acknowledge that these Terms are between you and Myo, not Apple, and that Apple is not responsible for the App or its content. Apple is a third-party beneficiaryof these Terms and may enforce them against you. Apple has no obligation to provide maintenance or support for the App, and any product warranty claims are our responsibility (or are subject to Apple’s refund policy), not Apple’s.
23. Contact
Questions about these Terms: [email protected]
PixelPort LLC, 7901 4th St N, Ste 300, St. Petersburg, FL 33702, United States.
Privacy Policy · [email protected]
© 2026 PixelPort LLC. Myo is not affiliated with, endorsed by, or sponsored by any GLP-1 manufacturer.